Literature DB >> 6272993

An update on the biochemistry of 5-fluorouracil.

B Ardalan, R Glazer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272993     DOI: 10.1016/s0305-7372(81)80014-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  12 in total

1.  In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.

Authors:  Y Sugimoto; Y Ohe; K Nishio; T Ohmori; Y Fujiwara; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  The Leishmania donovani UMP synthase is essential for promastigote viability and has an unusual tetrameric structure that exhibits substrate-controlled oligomerization.

Authors:  Jarrod B French; Phillip A Yates; D Radika Soysa; Jan M Boitz; Nicola S Carter; Bailey Chang; Buddy Ullman; Steven E Ealick
Journal:  J Biol Chem       Date:  2011-04-19       Impact factor: 5.157

4.  Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.

Authors:  S Takeda; J Yamashita; H Saito; J Uchida; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Authors:  Cary A Presant; Joth Jacobson; Walter Wolf; Victor Waluch; Ilene C Weitz; John S Macdonald
Journal:  Invest New Drugs       Date:  2002-11       Impact factor: 3.850

6.  Comparative study of the effects of PEGylated interferon-α2a versus 5-fluorouracil on cancer stem cells in a rat model of hepatocellular carcinoma.

Authors:  Tarek Kamal Motawi; Noha Ahmed El-Boghdady; Abeer Mostafa El-Sayed; Hebatullah Samy Helmy
Journal:  Tumour Biol       Date:  2015-08-26

Review 7.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

Review 8.  Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors:  P H Ellims
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

9.  In vivo effects of immunomodulators in a murine model of Fluorouracil-induced mucositis.

Authors:  David Tung; Peter H Cheung; Gregory Tudor; Catherine Booth; Saurabh Saha
Journal:  Curr Ther Res Clin Exp       Date:  2011-12

10.  Effect of 5-fluorouracil combination therapy on RNA processing in human colonic carcinoma cells.

Authors:  D A Greenhalgh; J H Parish
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.